Ocular Therapeutix, Inc. (NASDAQ:OCUL) Receives $16.25 Consensus Target Price from Analysts
Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eight ratings firms that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price target among […]
Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eight ratings firms that are covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average twelve-month price target among […]
